Literature DB >> 23614924

Imprint cytological feature of large cell neuroendocrine carcinoma of the gallbladder: a case report.

Takenobu Nakagawa1, Naomi Sakashita, Koji Ohnishi, Yoshihiro Komohara, Motohiro Takeya.   

Abstract

Large cell neuroendocrine carcinoma (LCNEC) is a rare poorly differentiated carcinoma with neuroendocrine differentiation showing aggressive clinical behavior. We herein report a case of gallbladder LCNEC, which was difficult to differentiate from poorly differentiated adenocarcinoma. An imprint cytology was very useful for the final diagnosis in this case. A 56-year-old male with left exophthalmos was admitted to the hospital. Radiological examinations revealed the presence of a left gallbladder tumor with orbital metastasis. The histological diagnosis was poorly differentiated adenocarcinoma, and intensive chemoradiotherapy was administered. Unfortunately, the patient died of extensive metastases 36 months after the initial onset of symptoms. An autopsy revealed a tumor mass in the gallbladder associated with multiple liver and peritoneal metastases. Imprint cytology of the main tumor revealed cytological features of LCNEC, and additional histological examinations confirmed this diagnosis. Although performing a histological examination is important for making a final diagnosis, imprint cytology is powerful tool for differential diagnosis of LCNEC, especially in patients with carcinoma with poor differentiation.

Entities:  

Mesh:

Year:  2013        PMID: 23614924     DOI: 10.2152/jmi.60.149

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  2 in total

1.  Rare case of a gallbladder neuroendocrine carcinoma.

Authors:  Masakuni Fujii; Hiroaki Saito; Junji Shiode
Journal:  Clin J Gastroenterol       Date:  2018-07-12

Review 2.  Mixed large cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder: a case report and brief review of the literature.

Authors:  Wei Liu; Lei Wang; Xiao-dong He; Cheng Feng; Xiao-yan Chang; Zhao-hui Lu
Journal:  World J Surg Oncol       Date:  2015-03-18       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.